nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Anagrelide for platelet-directed cytoreduction in polycythemia vera: Insights into utility and safety outcomes from a large multi-center database
|
Rippel, Noa |
|
|
119 |
C |
p. |
artikel |
2 |
Clinical and biological relevance of CREB3L1 in Philadelphia chromosome-negative myeloproliferative neoplasms
|
De Marchi, Federico |
|
|
119 |
C |
p. |
artikel |
3 |
Clinical experience with frontline Hyper-CVAD-based regimens, including Hyper-CVAD plus ponatinib, in patients with acute lymphoblastic leukemia treated at a comprehensive cancer center
|
Othman, Tamer |
|
|
119 |
C |
p. |
artikel |
4 |
Editorial Board
|
|
|
|
119 |
C |
p. |
artikel |
5 |
Epidemiologic evaluation of clinical outcomes in ethnic minorities with myelodysplastic syndromes
|
Molina, Alfonso |
|
|
119 |
C |
p. |
artikel |
6 |
Major clinical response in a patient with leukemia cutis treated with the bromodomain inhibitor PLX51107 and azacitidine
|
Kim, Kunhwa |
|
|
119 |
C |
p. |
artikel |
7 |
Outcomes and hospitalization patterns of patients with acute myelogenous leukemia treated with frontline CPX-351 or HMA/venetoclax
|
Chojecki, Aleksander L. |
|
|
119 |
C |
p. |
artikel |
8 |
Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis
|
Lucijanic, Marko |
|
|
119 |
C |
p. |
artikel |
9 |
Re-induction versus salvage for D14-resiudal acute myeloid leukemia: A retrospective multi-center study
|
Frisch, Avraham |
|
|
119 |
C |
p. |
artikel |
10 |
2022 update on the clinical outcome of coronavirus disease 2019 in haemato-oncology patients
|
Bradwell, Susie |
|
|
119 |
C |
p. |
artikel |